An mRNA cancer vaccine carries its own immune booster and lights up when it starts working, showing treatment success in mice ...

Across several clinical outcomes, including 28-day mortality, beta-blocker esmolol was more effective than standard care and ...

Clevetura might have just changed the game. The CLVX S is a compact touch sensitive keyboard where the keys themselves become ...

BRAFTOVI + MEKTOVI continued to show a substantial median overall survival benefit of 47.6 months in treatment-naïve patients with BRAF V600E-mutant metastatic non-small cell lung cancer after ...